LogicFlo, a Boston-based startup, raised $2.7M in seed funding led by Lightspeed to scale its AI agent platform designed for regulated life sciences work. The company’s intelligent agents assist pharma, biotech, and medtech teams in high-compliance tasks like medical writing and regulatory documentation, cutting timelines from weeks to hours. Already deployed in global organizations, LogicFlo’s agents operate within human-in-the-loop systems tailored to each company’s SOPs and compliance needs. The funding will support product expansion, deeper system integrations, and team growth.
